In addition, Lilly continues to offer Insulin Lispro Injection (100 units/mL), the non-branded version of Humalog U-100, at a 50 percent lower list price of $137.35 per vial and $265.20 for a ...

Effective in the fourth quarter, the list price of Humalog 100 units/mL—the company’s most commonly prescribed insulin—and insulin human (Humulin) injection 100 units/mL will be cut by 70%.

For most of our insulin products, including Humalog® (insulin lispro injection) 100 units/mL and Insulin Lispro Injection 100 units/mL, we have more than one presentation option, such as vials ...

Lilly's Insulin Lispro Injection, 100 units/ml, will now have a 70% lower list price than Humalog U-100, starting Jan. 1, 2022.

The Food and Drug Administration (FDA) has expanded the approval for Lyumjev ® (insulin lispro-aabc injection) U-100 (100 Units/mL) to include administration via continuous subcutaneous insulin ...